Cargando…
Efficacy and Safety of Modified Yupingfeng Nasal Spray in Controlling the Recurrence of Persistent and Moderate-Severe Allergic Rhinitis: Study Protocol for a Multicenter, Open-Label, Randomized, and Parallel-Arm Trial
BACKGROUND: Recurrent episode of allergic rhinitis (AR) is one of the leading illnesses that affects patients. However, there is little research evidence to support pharmacotherapy for AR recurrence. Therefore, this study was designed to explore the efficacy of pharmacotherapy in the control of the...
Autores principales: | Liu, Ting, Lu, Bing-Qing, Wang, Dan-Dan, Liao, Chao, Chiang, Han-Jen, Zhang, Rong, Xi, Yuan, Tian, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385272/ https://www.ncbi.nlm.nih.gov/pubmed/35990824 http://dx.doi.org/10.1155/2022/4666332 |
Ejemplares similares
-
Okbyungpoongsan (Yupingfeng) for treating allergic rhinitis: A protocol for the systematic review of controlled trials
por: Lee, Minseong, et al.
Publicado: (2018) -
Fluticasone furoate nasal spray in the treatment of allergic rhinitis
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2008) -
Psychometric validation of the experience with allergic rhinitis nasal spray questionnaire
por: Crawford, Bruce, et al.
Publicado: (2011) -
Noninterventional Open-Label Trial Investigating the Efficacy and Safety of Ectoine Containing Nasal Spray in Comparison with Beclomethasone Nasal Spray in Patients with Allergic Rhinitis
por: Sonnemann, Uwe, et al.
Publicado: (2014) -
Efficacy and tolerability of levocabastine and azelastine nasal sprays for the treatment of allergic rhinitis
por: Mösges, Ralph, et al.
Publicado: (1995)